Published in Proc Natl Acad Sci U S A on July 20, 1999
Genome-wide association study identifies candidate genes for male fertility traits in humans. Am J Hum Genet (2012) 2.56
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22
Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet (2000) 2.19
Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.84
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet (2011) 1.51
Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome. Mol Cell Endocrinol (2011) 1.38
Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2002) 1.12
Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 1.06
Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One (2011) 1.00
Intraovarian control of early folliculogenesis. Endocr Rev (2014) 0.99
Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.98
Genetics of the polycystic ovary syndrome. Mol Cell Endocrinol (2012) 0.97
Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. Mol Hum Reprod (2009) 0.96
Linkage of regulators of TGF-β activity in the fetal ovary to polycystic ovary syndrome. FASEB J (2011) 0.95
Contemporary genetic technologies and female reproduction. Hum Reprod Update (2011) 0.95
The genetic basis of female reproductive disorders: etiology and clinical testing. Mol Cell Endocrinol (2013) 0.94
Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol (2013) 0.91
Small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA), a candidate gene for polycystic ovary syndrome. Hum Reprod (2008) 0.88
Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASP. Reprod Biol Endocrinol (2009) 0.87
Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol Metab (2015) 0.86
Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data. Theor Biol Med Model (2009) 0.86
Fibrillins in adult human ovary and polycystic ovary syndrome: is fibrillin-3 affected in PCOS? J Histochem Cytochem (2010) 0.85
The Genetics of Infertility: Current Status of the Field. Curr Genet Med Rep (2013) 0.85
Ovarian hypertension: polycystic ovary syndrome. Endocrinol Metab Clin North Am (2011) 0.85
Family association study between INSR gene polymorphisms and PCOS in Han Chinese. Reprod Biol Endocrinol (2011) 0.84
Genetics of polycystic ovary syndrome. Hippokratia (2009) 0.84
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev (2016) 0.83
FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome. Hum Reprod (2008) 0.83
A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome. Fertil Steril (2010) 0.83
MicroRNAs Related to Polycystic Ovary Syndrome (PCOS). Genes (Basel) (2014) 0.82
Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2011) 0.82
Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity. J Clin Endocrinol Metab (2016) 0.81
The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal size. J Clin Endocrinol Metab (2010) 0.80
The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma. PPAR Res (2007) 0.80
2D:4D ratio in children at familial high-risk for eating disorders: The role of prenatal testosterone exposure. Am J Hum Biol (2013) 0.80
Association of TRB3 Q84R polymorphism with polycystic ovary syndrome in Chinese women. Reprod Biol Endocrinol (2011) 0.80
Lipidomic analysis of plasma samples from women with polycystic ovary syndrome. Metabolomics (2014) 0.79
Association of CAPN10 SNPs and haplotypes with polycystic ovary syndrome among South Indian Women. PLoS One (2012) 0.79
Effect of maternal PCOS and PCOS-like phenotype on the offspring's health. Mol Cell Endocrinol (2015) 0.78
Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study. Genet Test Mol Biomarkers (2014) 0.78
The role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 0.78
Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome. PLoS One (2011) 0.78
Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome. J Clin Transl Endocrinol (2015) 0.78
A paradigm for finding genes for a complex human trait: polycystic ovary syndrome and follistatin. Proc Natl Acad Sci U S A (1999) 0.77
Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review. J Assist Reprod Genet (2013) 0.77
No association between the microsatellite polymorphism (TTTTA)n in the promoter of the CYP11A gene and ovarian hyperstimulation syndrome. J Assist Reprod Genet (2006) 0.75
Association of luteinizing hormone chorionic gonadotropin receptor gene polymorphism (rs2293275) with polycystic ovarian syndrome. Genet Test Mol Biomarkers (2015) 0.75
Genetics of PCOS: A systematic bioinformatics approach to unveil the proteins responsible for PCOS. Genom Data (2016) 0.75
SNP analysis of follistatin gene associated with polycystic ovarian syndrome. Adv Appl Bioinform Chem (2010) 0.75
Electrophoretic Techniques for the Detection of Human Microsatellite D19S884. Malays J Med Sci (2015) 0.75
Endocrinal and autoimmune linkage: Evidences from a controlled study of subjects with polycystic ovarian syndrome. J Hum Reprod Sci (2016) 0.75
The Effects of Exercise on Expression of CYP19 and StAR mRNA in Steroid-Induced Polycystic Ovaries of Female Rats. Int J Fertil Steril (2017) 0.75
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet (1993) 51.42
Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet (1996) 39.80
Genetic dissection of complex traits. Science (1994) 29.54
The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet (1995) 24.52
A note on the application of the transmission disequilibrium test when a parent is missing. Am J Hum Genet (1995) 7.79
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev (1997) 5.83
Polycystic ovary syndrome. N Engl J Med (1995) 5.30
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab (1999) 5.28
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet (1995) 3.87
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A (1998) 2.86
A simple method to detect linkage for rare recessive diseases: an application to juvenile diabetes. Clin Genet (1979) 2.70
Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) (1992) 1.99
Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome. Lancet (1997) 1.91
The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab (1996) 1.80
Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet (1994) 1.58
Mutations in the insulin receptor gene. Endocr Rev (1992) 1.55
Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes (1992) 1.54
Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol (1998) 1.40
Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest (1995) 1.32
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab (1992) 1.26
Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proc Soc Exp Biol Med (1997) 1.21
Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) (1993) 1.18
Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet (1997) 1.17
Hereditary factors in the Stein-Leventhal syndrome. Am J Obstet Gynecol (1968) 1.16
Mutant insulin receptors in syndromes of insulin resistance. Baillieres Clin Endocrinol Metab (1996) 1.08
Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes (1994) 1.08
Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab (1999) 1.06
Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms. Diabetes (1991) 1.04
Phenotype and genotype in polycystic ovary syndrome. Recent Prog Horm Res (1998) 1.04
A twin study of polycystic ovary syndrome. Fertil Steril (1995) 1.03
Do hyperandrogenic women with normal menses have polycystic ovary syndrome? Fertil Steril (1999) 0.93
Familial polycystic ovarian disease. Endocrinol Metab Clin North Am (1988) 0.91
Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J Clin Endocrinol Metab (1996) 0.90
Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome. Metabolism (1994) 0.85
5' polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries. J Clin Endocrinol Metab (1996) 0.84
The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome. Hum Reprod (1994) 0.84
TDT clarification. Am J Hum Genet (1999) 0.84
Two distinct signaling pathways activated by activin A in glucose-responsive pancreatic beta-cell lines. J Mol Endocrinol (1996) 0.82
The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet (1995) 24.52
The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet (1996) 11.61
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66
A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58
Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet (2000) 6.21
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab (1999) 5.28
The insulin gene and susceptibility to IDDM. Genet Epidemiol (1989) 5.24
Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology (1986) 4.89
Insulin-gene sharing in sib pairs with insulin-dependent diabetes mellitus: no evidence for linkage. Am J Hum Genet (1988) 4.86
The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem (2001) 4.74
Estimation of genetic variation at the DNA level from restriction endonuclease data. Proc Natl Acad Sci U S A (1981) 4.71
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol (1998) 3.86
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest (2001) 3.41
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science (1995) 3.29
Regional linguistic and genetic differences among Yanomama indians. Science (1974) 2.87
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci U S A (1998) 2.86
Autosomal dominant "Opitz" GBBB syndrome due to a 22q11.2 deletion. Am J Med Genet (1995) 2.70
"CATCH 22" sans cardiac anomaly, thymic hypoplasia, cleft palate, and hypocalcaemia: cAtch 22. A common result of 22q11 deficiency? J Med Genet (1994) 2.69
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab (2001) 2.66
Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genet Med (2001) 2.57
Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med (2001) 2.56
Genetics of quantitative variation in human gene expression. Cold Spring Harb Symp Quant Biol (2003) 2.55
The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem (1999) 2.45
Premature rupture of the fetal membranes. N Engl J Med (1998) 2.42
Psychoeducational profile of the 22q11.2 microdeletion: A complex pattern. J Pediatr (1999) 2.38
A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab (1998) 2.35
Gene dosage and suceptibility to insulin-dependent diabetes. Ann Hum Genet (1980) 2.29
The incidence of hyponatremia during prolonged ultraendurance exercise. Med Sci Sports Exerc (1990) 2.21
Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials. BMJ (2010) 2.19
Structure, sequence and polymorphism in the HLA-D region. Immunol Rev (1985) 2.16
The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med (1996) 2.08
The genetics of susceptibility to multiple sclerosis. Epidemiol Rev (1982) 2.00
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab (1998) 1.97
Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA (2001) 1.90
Six HLA-D region alpha-chain genes on human chromosome 6: polymorphisms and associations of DC alpha-related sequences with DR types. Proc Natl Acad Sci U S A (1984) 1.90
A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet (1998) 1.87
Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod (1995) 1.87
The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev (1982) 1.86
Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod (1998) 1.85
Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. J Clin Endocrinol Metab (2005) 1.84
Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol (1999) 1.84
Current distribution in the brain from surface electrodes. Anesth Analg (1969) 1.83
EEG electrode sensitivity--an application of reciprocity. IEEE Trans Biomed Eng (1969) 1.81
Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev (2003) 1.80
Tightly clustered 11q23 and 22q11 breakpoints permit PCR-based detection of the recurrent constitutional t(11;22). Am J Hum Genet (2000) 1.78
The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab (2009) 1.77
Association of chromosome 22q11 deletion with isolated anomalies of aortic arch laterality and branching. J Am Coll Cardiol (2001) 1.75
A health profile of adults in a Northern Territory aboriginal community, with an emphasis on preventable morbidities. Aust N Z J Public Health (1997) 1.73
The effect of intercourse on pregnancy rates during assisted human reproduction. Hum Reprod (2000) 1.71
Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet (1999) 1.71
Cat eye syndrome chromosome breakpoint clustering: identification of two intervals also associated with 22q11 deletion syndrome breakpoints. Cytogenet Cell Genet (1998) 1.70
The TDT reveals linkage and linkage disequilibrium in a rare disease. Genet Epidemiol (1995) 1.69
Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nat Genet (1995) 1.68
Risk factors for rapid repeat pregnancy among adolescent mothers: a review of the literature. J Pediatr Adolesc Gynecol (1998) 1.67
Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study. BMJ (2000) 1.65
Cerebellar atrophy in a patient with velocardiofacial syndrome. J Med Genet (1995) 1.64
Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity. J Biol Chem (1997) 1.59
Pharmacomechanical coupling in smooth muscle may involve phosphatidylinositol metabolism. Proc Natl Acad Sci U S A (1984) 1.58
Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest (2000) 1.58
A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Invest (1996) 1.57
Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum Mol Genet (1997) 1.56
Preliminary phenotypic map of chromosome 4p16 based on 4p deletions. Am J Med Genet (1995) 1.55
The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab (2001) 1.54
Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci U S A (1991) 1.54
Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab (2001) 1.53
Linkage-disequilibrium mapping without genotyping. Nat Genet (1998) 1.52
Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab (1987) 1.50
Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. Proc Natl Acad Sci U S A (1996) 1.50
Genetic studies on the Ticuna, an enigmatic tribe of Central Amazonas. Ann Hum Genet (1980) 1.49
Velo-cardio-facial syndrome and DiGeorge sequence with meningomyelocele and deletions of the 22q11 region. Am J Med Genet (1994) 1.49
Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet (2001) 1.49
Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nat Genet (1996) 1.44
Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc Natl Acad Sci U S A (1995) 1.44
Gamete intra-fallopian transfer: outcome following the elective or non-elective replacement of two, three or four oocytes. Hum Reprod (1993) 1.44
What should we do with donated embryos that may be genetically affected? Hum Reprod (2004) 1.43
Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab (2003) 1.42
Evaluation of renal function and fluid homeostasis during recovery from exercise-induced hyponatremia. J Appl Physiol (1985) (1991) 1.42
Genetic studies of the Macushi and Wapishana Indians. I. Rare genetic variants and a "private polymorphism' of esterase A. Hum Genet (1977) 1.41
Classical Noonan syndrome is not associated with deletions of 22q11. Am J Med Genet (1995) 1.41
Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene (1994) 1.40
Operative endoscopy: the pressing need for a structured training and credentialing process. Fertil Steril (1992) 1.38
MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis. Proc Natl Acad Sci U S A (1997) 1.38
Altered autophosphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome. Fertil Steril (2001) 1.37
Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis Rheum (1997) 1.36
Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril (2001) 1.36
Pituitary function in Sheehan's syndrome. Obstet Gynecol (1984) 1.36
Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab (1994) 1.35
Adipokines: implications for female fertility and obesity. Reproduction (2005) 1.35
Dysphagia in children with a 22q11.2 deletion: unusual pattern found on modified barium swallow. J Pediatr (2000) 1.35
Ascertainment considerations in the analysis of affected sib shared haplotype data. Genet Epidemiol Suppl (1986) 1.34
Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update (2011) 1.34